AstraZeneca AB is a global biopharmaceutical company headquartered in Stockholm, Sweden. The organization focuses on the discovery, development, and commercialization of prescription medicines, primarily in the areas of oncology, cardiovascular, renal, and respiratory diseases. AstraZeneca operates in more than 100 countries and has a diverse portfolio of products that include both patented and generic medications.
The company was formed in 1999 through the merger of Sweden's Astra AB and the UK's Zeneca Group. Since its inception, AstraZeneca has invested significantly in research and development to advance medical science and improve patient outcomes. The company collaborates with various stakeholders, including academic institutions and healthcare providers, to drive innovation and enhance its therapeutic offerings.
AstraZeneca is also known for its commitment to sustainability and corporate responsibility, focusing on reducing its environmental impact and improving access to healthcare. The company engages in various initiatives aimed at addressing global health challenges and promoting responsible business practices within the pharmaceutical industry.